163 results
8-K
EX-99.1
TGTX
TG Therapeutics Inc
1 May 24
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
7:05am
sclerosis (RMS) is a chronic demyelinating disease of the central nervous system (CNS) and includes people with relapsing-remitting multiple sclerosis (RRMS
8-K
EX-99.1
TGTX
TG Therapeutics Inc
28 Feb 24
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
7:24am
MULTIPLE SCLEROSIS
Relapsing multiple sclerosis (RMS) is a chronic demyelinating disease of the central nervous system (CNS) and includes people
8-K
EX-99.1
TGTX
TG Therapeutics Inc
10 Jan 24
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones
7:37am
at www.briumvipatientsupport.com.
ABOUT MULTIPLE SCLEROSIS
Relapsing multiple sclerosis (RMS) is a chronic demyelinating disease of the central nervous
8-K
EX-99.1
TGTX
TG Therapeutics Inc
1 Nov 23
TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
7:33am
be accessed at www.briumvipatientsupport.com.
ABOUT MULTIPLE SCLEROSIS
Relapsing multiple sclerosis (RMS) is a chronic demyelinating disease of the central
8-K
EX-99.1
48mx0uho wjhlu
1 Aug 23
TG Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
7:29am
8-K
EX-99.1
13kmz04i9 b9w86rms
1 May 23
TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
7:35am
8-K
EX-99.1
tduhe aakl
28 Dec 22
U.S. Commercial launch expected Q1 2023
4:30pm
S-3ASR
gcn eixa0ncq625
2 Sep 22
Automatic shelf registration
4:31pm
8-K
vzzny2jx5s0n2u19d
18 Apr 22
TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
7:30am
8-K
EX-99.1
qojrslq 21kdwawtc1c
18 Apr 22
TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
7:30am
8-K
EX-99.1
lnqxgbt8a1g r7
1 Mar 22
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2021 Financial Results
8:15am
8-K
5kdkjettx0
27 Jan 22
Other Events
10:01am
8-K
EX-99.1
cft2q
30 Nov 21
TG Therapeutics Provides Regulatory Update
7:59am